Layer-by-layer coated lipid-polymer hybrid nanoparticles designed for use in anticancer drug delivery
- Authors
- Ramasamy, Thiruganesh; Tuan Hiep Tran; Choi, Ju Yeon; Cho, Hyuk Jun; Kim, Jeong Hwan; Yong, Chul Soon; Choi, Han-Gon; Kim, Jong Oh
- Issue Date
- Feb-2014
- Publisher
- ELSEVIER SCI LTD
- Keywords
- Layer-by-layer; Polyelectrolyte multilayer; Hybrid solid lipid nanoparticles; Chitosan; Hyaluronic acid; Doxorubicin
- Citation
- CARBOHYDRATE POLYMERS, v.102, pp 653 - 661
- Pages
- 9
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- CARBOHYDRATE POLYMERS
- Volume
- 102
- Start Page
- 653
- End Page
- 661
- URI
- https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/23704
- DOI
- 10.1016/j.carbpol.2013.11.009
- ISSN
- 0144-8617
1879-1344
- Abstract
- Polyelectrolyte multilayers created via sequential adsorption of complimentary materials may be useful in the delivery of small molecules such as anti-cancer drugs. In this study, layer-by-layer (LbL) nanoarchitectures were prepared by step-wise deposition of naturally derived chitosan and hyaluronic acid on negatively charged hybrid solid lipid nanoparticles (SLNs). A doxorubicin/dextran sulfate complex was incorporated into the SLNs. This resulted in the production of spherical nanoparticles similar to 265 nm in diameter, with a zeta potential of approximately -12 mV. The nanoparticles were physically stable and exhibited controlled doxorubicin (DOX) release kinetics. Further pharmacokinetic manipulations revealed that in comparison with both free DOX and uncoated DOX-loaded SLNs, LbL-functionalized SLNs remarkably enhanced the circulation half-life and decreased the elimination rate of the drug. Cumulatively, our results suggest that this novel LbL-coated system, with a pH-responsive shell and molecularly targeted entities, has the potential to act as a vehicle to deliver medication to targeted tumor regions. (C) 2013 Elsevier Ltd. All rights reserved.
- Files in This Item
-
Go to Link
- Appears in
Collections - COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.